default author photo

Clément Droillard

International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)

Université de Lyon - Université Claude Bernard Lyon 1

Lyon, 69008

France

Centre International de Recherche en Infectiologie (CIRI) - Team VirPath, Univ Lyon, 14 Inserm, U1111

France

Université de Lyon - VirNext, Faculté de Médecine RTH Laennec

France

SCHOLARLY PAPERS

2

DOWNLOADS

123

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Host-Directed Repurposed Diltiazem Enhances the Antiviral Activity of Classic Antivirals Against Influenza and Sars-Cov-2

Number of pages: 36 Posted: 10 Dec 2024
affiliation not provided to SSRN, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université de Lyon - Université Claude Bernard Lyon 1, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada) and International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)
Downloads 67 (899,324)

Abstract:

Loading...

diltiazem, host-directed antivirals, drug combination, Respiratory Viruses, Influenza, SARS-COV-2

2.

New Mucosal Bivalent Live-Attenuated Vaccine is Protective Against Human Metapneumovirus and Respiratory Syncytial Virus

Number of pages: 48 Posted: 06 Jul 2023
Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université Laval- Infectious Disease Research Centre, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université de Lyon - Université Claude Bernard Lyon 1, University of Paris-Saclay - UVSQ, VIM, University of Claude Bernard Lyon 1 - CIRI, University of Paris-Saclay - UVSQ, VIM, Université Laval- Infectious Disease Research Centre, Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada) and International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)
Downloads 56 (1,000,027)

Abstract:

Loading...

RSV, HMPV, chimeric virus, bivalent vaccine, live attenuated vaccine, vectored vaccine, reverse genetics, gene insertion, respiratory viruses, pneumovirus, bronchiolitis